Grove AI Secures $4.9M to Revolutionize Clinical Trials
Grove AI, a next-generation clinical trial management company, has raised $4.9 million in seed funding, led by A* with support from Afore Capital, LifeX Ventures, Pear VC, Upfront Ventures, and industry-leading angels. This funding will enable Grove to scale its team and product, addressing inefficiencies in clinical trials by creating participant-centered ecosystems powered by real-time data and AI-driven insights.
